Lung biopsy: Special techniques

Seminars in Respiratory and Critical Care Medicine

Volumn 29, Issue 4, 2008, Pages 335-349

  Cham, Matthew D ^a   Lane, Maureen E ^a   Henschke, Claudia I ^a   Yankelevitz, David F ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Computed tomography; Fine needle biopsy; Lung biopsy; Lung cancer; Lung neoplasms; Pulmonary nodule

Indexed keywords

ASPIRATION; BIOPSY TECHNIQUE; BLEEDING; BLOOD AUTOTRANSFUSION; BREATHING MECHANICS; CYTOLOGY; DIAGNOSTIC ACCURACY; FOLLOW UP; HEMOPTYSIS; LUNG BIOPSY; LUNG NODULE; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; NEEDLE BIOPSY; PATIENT POSITIONING; PNEUMOTHORAX; PRIORITY JOURNAL; REVIEW; SEDATION;

BIOPSY, NEEDLE; CYTODIAGNOSIS; HUMANS; LUNG NEOPLASMS; PATIENT CARE PLANNING; POSTURE; RADIOGRAPHY, INTERVENTIONAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 48249147821     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1081278     Document Type: Review

References (63)

1. International Early Lung Cancer Action Program Investigators; Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-1771
2. Manhire A, Charig M, Clelland C, et al; BTS. Guidelines for radiologically guided lung biopsy. Thorax 2003;58:920-936
3. Cox JE, Chiles C, McManus CM, Aquino SL, Choplin RH. Transthoracic needle aspiration biopsy: variables that affect risk of pneumothorax. Radiology 1999;212:165-168
4. Poe RH, Kallay MC, Wicks CM, Odoroff CL. Predicting risk of pneumothorax in needle biopsy of the lung. Chest 1984;85:232-235
5. Fish GD, Stanley JH, Miller KS, Schabel SI, Sutherland SE. Postbiopsy pneumothorax: estimating the risk by chest radiography and pulmonary function tests. AJR Am J Roentgenol 1988;150:71-74
6. Kazerooni EA, Lim FT, Mikhail A, Martinez FJ. Risk of pneumothorax in CT-guided transthoracic needle aspiration biopsy of the lung. Radiology 1996;198:371-375
7. Li H, Boiselle PM, Shepard JO, Trotman-Dickenson B, McLoud TC. Diagnostic accuracy and safety of CT-guided percutaneous needle aspiration biopsy of the lung: comparison of small and large pulmonary nodules. AJR Am J Roentgenol 1996;167:105-109
8. García-Río F, Pino JM, Casadevall J, et al. Use of spirometry to predict risk of pneumothorax in CT-guided needle biopsy of the lung. J Comput Assist Tomogr 1996;20:20-23
9. Laurent F, Michel P, Latrabe V, Tunon de Lara M, Marthan R. Pneumothoraces and chest tube placement after CT-guided transthoracic lung biopsy using a coaxial technique: incidence and risk factors. AJR Am J Roentgenol 1999;172:1049-1053
10. Ko JP, Shepard JO, Drucker EA, et al. Factors influencing pneumothorax rate at lung biopsy: are dwell time and angle of pleural puncture contributing factors? Radiology 2001;218:491-496
11. Yamagami T, Nakamura T, Iida S, Kato T, Nishimura T. Management of pneumothorax after percutaneous CT-guided lung biopsy. Chest 2002;121:1159-1164
12. Geraghty PR, Kee ST, McFarlane G, Razavi MK, Sze DY, Dake MD. CT-guided transthoracic needle aspiration biopsy of pulmonary nodules: needle size and pneumothorax rate. Radiology 2003;229:475-481
13. Kucuk CU, Yilmaz A, Yilmaz A, Akkaya E. Computed tomography-guided transthoracic fine-needle aspiration in diagnosis of lung cancer: a comparison of single-pass needle and multiple-pass coaxial needle systems and the value of immediate cytological assessment. Respirology 2004;9:392-396
14. Aviram G, Schwartz DS, Meirsdorf S, Rosen G, Greif J, Graif M. Transthoracic needle biopsy of lung masses: a survey of techniques. Clin Radiol 2005;60:370-374
15. Yankelevitz DF, Davis SD, Chiarella D, Henschke CI. Needle-tip repositioning during computed-tomography-guided transthoracic needle aspiration biopsy of small deep pulmonary lesions: minor adjustments make a big difference. J Thorac Imaging 1996;11:279-282
16. Yankelevitz DF, Henschke CI, Davis SD. Angulated needle placement in CT-guided percutaneous needle biopsy of the thorax. Clin Imaging 1993;17:124-125
17. Yankelevitz DF, Henschke CI, Davis SD. Percutaneous CT biopsy of chest lesions: an in vitro analysis of the effect of partial volume averaging on needle positioning. AJR Am J Roentgenol 1993;161:273-278
18. Westcott JL. Needle biopsy of the chest. In: Tavares J, Ferrucci J, eds. Imaging - Diagnosis - Intervention. Vol 1, ch 45. Philadelphia: Lippincott; 1993:1-13
19. Khouri NF, Stitik FP, Erozan YS, et al. Transthoracic needle aspiration biopsy of benign and malignant lung lesions. AJR Am J Roentgenol 1985;144:281-288
20. Wallace MJ, Krishnamurthy S, Broemeling LD, et al. CT-guided percutaneous fine-needle aspiration biopsy of small (< or = 1-cm) pulmonary lesions. Radiology 2002;225:823-828
21. Yeow KM, Tsay PK, Cheung YC, Lui KW, Pan KT, Chou AS. Factors affecting diagnostic accuracy of CT-guided coaxial cutting needle lung biopsy: retrospective analysis of 631 procedures. J Vasc Interv Radiol 2003;14:581-588
22. Yeow KM, Su IH, Pan KT, et al. Risk factors of pneumothorax and bleeding: multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies. Chest 2004;126:748-754
23. Yankelevitz DF, Henschke CI, Koizumi JH, Altorki NK, Libby D. CT-guided transthoracic needle biopsy of small solitary pulmonary nodules. Clin Imaging 1997;21:107-110
24. Moore EH. Technical aspects of needle aspiration lung biopsy: a personal perspective. Radiology 1998;208:303-318
25. Yankelevitz DF, Davis SD, Henschke CI. Aspiration of a large pneumothorax resulting from transthoracic needle biopsy. Radiology 1996;200:695-697
26. Yamagami T, Kato T, Hirota T, Yoshimatsu R, Matsumoto T, Nishimura T. Usefulness and limitation of manual aspiration immediately after pneumothorax complicating interventional radiological procedures with the transthoracic approach. Cardiovasc Intervent Radiol 2006;29:1027-1033
27. Yankelevitz DF, Davis SD, Chiarella DA, Henschke CI. Pitfalls in CT-guided transthoracic needle biopsy of pulmonary nodules. Radiographics 1996;16:1073-1084
28. Tomiyama N, Yasuhara Y, Nakajima Y, et al. CT-guided needle biopsy of lung lesions: a survey of severe complication based on 9783 biopsies in Japan. Eur J Radiol 2006;59:60-64
29. Lang EK, Ghavami R, Schreiner VC, Archibald S, Ramirez J. Autologous blood clot seal to prevent pneumothorax at CT-guided lung biopsy. Radiology 2000;216:93-96
30. Moore EH, Shepard JA, McLoud TC, Templeton PA, Kosiuk JP. Positional precautions in needle aspiration lung biopsy. Radiology 1990;175:733-735
31. Moore EH, LeBlanc J, Montesi SA, Richardson ML, Shepard JA, McLoud TC. Effect of patient positioning after needle aspiration lung biopsy. Radiology 1991;181:385-387
32. Collings CL, Westcott JL, Banson NL, Lange RC. Pneumothorax and dependent versus nondependent patient position after needle biopsy of the lung. Radiology 1999;210:59-64
33. Cantin L, Chartrand-Lefebvre C, Samson L, et al. Lack of effect of position restriction after transthoracic biopsy. Radiology 2001;219:295
34. Tanisaro K. Patient positioning after fine needle lung biopsy-effect on pneumothorax rate. Acta Radiol 2003;44:52-55
35. Masterson AV, Haslam P, Logan PM, Lee MJ. Patient positioning after lung biopsy: influence on the incidence of pneumothorax. Can Assoc Radiol J 2003;54:31-34
36. Vazquez MF, Yankelevitz DF. The radiologic appearance of solitary pulmonary nodules and their cytologic-histologic correlation. Semin Ultrasound CT MR 2000;21:149-162
37. Austin JH, Cohen MB. Value of having a cytopathologist present during percutaneous fine-needle aspiration biopsy of lung: report of 55 cancer patients and metaanalysis of the literature. AJR Am J Roentgenol 1993;160:175-177
38. Santambrogio L, Nosotti M, Bellaviti N, Pavoni G, Radice F, Caputo V. CT-guided fine-needle aspiration cytology of solitary pulmonary nodules: a prospective, randomized study of immediate cytologic evaluation. Chest 1997;112:423-425
39. Roger V, Nasiell M, Linden M, Enstead I. Cytologic differential diagnosis of bronchiolo-alveolar carcinoma and bronchogenic carcinoma. Acta Cytol 1976;20:303-307
40. Meyerson M, Franklin WA, Kelley MJ. Molecular classification and molecular genetics of human lung cancers. Semin Oncol 2004;31(1, Suppl 1):4-19
41. Nacht M, Dracheva T, Gao Y, et al. Molecular characteristics of non-small cell lung cancer. Proc Natl Acad Sci U S A 2001;98:15203-15208
42. Nguyen DM, Schrump DS. Lung cancer staging in the genomics era. Thorac Surg Clin 2006;16:329-337
43. Lane ME, Yankelevitz DF, Henschke CI, et al. Patterns of gene expression in pulmonary fine needle aspirates (FNA) with diverse radiographic appearances. J Clin Oncol 2004;22(14S):9587
44. Lim EH, Aggarwal A, Agasthian T, et al. Feasibility of using low-volume tissue samples for gene expression profiling of advanced non-small cell lung cancers. Clin Cancer Res 2003;9(16 Pt 1):5980-5987
45. Giacomini KM, Brett CM, Altman RB, et al; Pharmacogenetics Research Network. The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther 2007;81:328-345
46. Kiyohara C, Takayama K, Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 2006;54:267-283
47. Tebbutt SJ, James A, Pare PD. Single-nucleotide polymorphisms and lung disease: clinical implications. Chest 2007;131:1216-1223
48. Hirsch FR, Varella-Garcia M, McCoy J, et al; Southwest Oncology Group. Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study. J Clin Oncol 2005;23:6838-6845
49. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-2139
50. Takano T, Ohe Y, Sakamoto H, et al. Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer. J Clin Oncol 2005;23:6829-6837
51. Angulo B, Suarez-Gauthier A, Lopez-Rios F, et al. Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification. J Pathol 2008;214:347-356
52. Daniele L, Macrì L, Schena M, et al. Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens. Mol Cancer Ther 2007;6:1223-1229
53. Sholl LM, John Iafrate A, Chou YP, et al. Validation of chromogenic in situ hybridization for detection of EGFR copy number amplification in nonsmall cell lung carcinoma. Mod Pathol 2007;20:1028-1035
54. Uzawa N, Sonoda I, Myo K, Takahashi K, Miyamoto R, Amagasa T. Fluorescence in situ hybridization for detecting genomic alterations of cyclin D1 and p16 in oral squamous cell carcinomas. Cancer 2007;110:2230-2239
55. Zhu H, Lam DC, Han KC, et al. High resolution analysis of genomic aberrations by metaphase and array comparative genomic hybridization identifies candidate tumour genes in lung cancer cell lines. Cancer Lett 2007;245:303-314
56. Mariadason JM, Augenlicht LH, Arango D. Microarray analysis in the clinical management of cancer. Hematol Oncol Clin North Am 2003;17:377-387
57. Abdel-Aziz HO, Takasaki I, Tabuchi Y, et al. High-density oligonucleotide microarrays and functional network analysis reveal extended lung carcinogenesis pathway maps and multiple interacting genes in NNK [4-(methylnitrosamino)-1-(3- pyridyle)-1-butanone] induced CD1 mouse lung tumor. J Cancer Res Clin Oncol 2007;133:107-115
58. Mayburd AL, Martlínez A, Sackett D, et al. Ingenuity network-assisted transcription profiling: identification of a new pharmacologic mechanism for MK886. Clin Cancer Res 2006;12:1820-1827
59. Pospisil P, Iyer LK, Adelstein SJ, Kassis AI. A combined approach to data mining of textual and structured data to identify cancer-related targets. BMC Bioinformatics 2006;7:354
60. Coulson JM, Ahmed SI, Quinn JP, Woll PJ. Detection of small cell lung cancer by RT-PCR for neuropeptides, neuropeptide receptors, or a splice variant of the neuron restrictive silencer factor. Methods Mol Med 2003;75:335-352
61. Zhou QH, Gong YL, Qin Y, et al. Value of diagnosing micrometastasis by nested RT-PCR in the peripheral blood and bone marrow in non-small cell lung cancer patients. Zhonghua Zhong Liu Za Zhi 2003;25:62-65
62. Stark AM, Hugo HH, Tscheslog H, Mehdorn HM. p53, BCL-2 and BAX in non-small cell lung cancer brain metastases: a comparison of real-time RT-PCR, ELISA and immunohistochemical techniques. Neurol Res 2007;29:435-440
63. Kikuchi T, Carbone DP. Proteomics analysis in lung cancer: challenges and opportunities. Respirology 2007;12:22-28